Investor Presentation • Nov 18, 2025
Investor Presentation
Open in ViewerOpens in native device viewer

Virtual
November 19th, 2025




Certain statements in this slide show, including those addressing the Company's beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forward-looking statements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, noforward-looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forward-looking statements. The Company undertakes noobligation about the contents nor to update the forward-looking statements to reflect events or circumstances that may arise after the date hereof.





Hi-Tech industrial group providing laser solutions with proprietary technologies and know how developed over 40 years

Listed on Euronext STAR Milan of Italian Stock Exchange since year 2000 and member of Euronext Tech Leaders


Active worldwide on several laser application segments andmarkets…

…progressively widening its globalwide presence achieving continuous growth over the years

40
YEARS OF EXPERIENCE

25
SUBSIDIARIES

9
COUNTRIES WITH DIRECT PRESENCE

9
PLANTS

Our energy based systems improve people's well-being and life quality.
In the SURGICAL SECTOR, our minimally invasive technology systems minimize pain, side effects and risks of surgical procedures and hospitalization days.
In the AESTHETIC SECTOR, our systems satisfy the growing desire of individuals to improve their appearance also reducing pathological or painful imperfections.

Our LASER CUTTING and MARKING SYSTEMS Improve the productivity of our customers manufacturing plants also limiting the environmental impact of manufacturing processes minimizing waste, fumes generated by the process, use of chemical additives, and allowing to eliminate the need for inks, solvents or glues within the process.

CONSERVATION
Our LASER SYSTEMS PRESERVE artworks of the universal heritage of our communities.

EthiFinance
ESG ratings

MSCI ESG RATINGS
Sustainalytics
Create value over time and be ready to successfully meet the future challenges

5 R&D dept

15 MLN
Yearly R&D investments

30 Patents

120 R&D specialists

60.000
Laser sources installed worldwide

ISO 9001 e ISO 13485
Certifications

ISO 14064
El.En., Deka Mela and Quanta

50 Quality & Regulatory specialists

~18% under 30 years
>1.400 employees
33% of employees have a university degree and over 90% hold either a degree or a high school diploma.

WELFARE at the heart of business projects.
Workspaces were renewed for several Group companies: employees well-being was increased and plants'energy efficiency as well

24.000 HOURS
Training

7 Photovoltaic systems active in 2024
2 Photovoltaic plants in progress

16%
Self-produced electrical energy share of the annual total consumption

39%
Annual electricity consumption comes from renewable sources

All data refers to the Group without Chinese divi












| • | Mordor Intelligence | CAGR 13,4% to 2028 |
|---|---|---|
| • | Fortune business insights | CAGR 13,1% to 2030 |
| • | Global Market Insights | CAGR 14,5% to 2032 |
| • | Research and Markets | CAGR 13,2% to 2030 |
Research and Markets
CAGR 9,45% 2023- 2028
\$ 3,7Bn 2023 Market Size
Tecnavio CAGR 10,9% 2023- 2028
\$3,9Bn 2023 Market Size






•Size: \$17,48 billion in 2021
•Expected CAGR to 2030: 9,1%
Source: Grand view research




Electronics

Optics
Photonics
Mechanics

Fluid dynamics

Power electronics

Software

Aesthetics

Surgery

Dermatology

Physiotherapy


Art Conservation








Physiotherapy




Skin Rejuvenation


Surgery










Innovative





painful





User friendly

LINEAR CUBE


| Teleborsa: |
|---|
| distribution |
| and |
| and commercial |
| use |
| strictly |
| prohibite |
| Euro '000 | 30/09/2024 | % | 30/09/2025 | % | Var. % |
|---|---|---|---|---|---|
| unaudited | unaudited | ||||
| Medical | 294.013 | 72,4% | 307.537 | 72,9% | 4,6% |
| Industrial | 112.219 | 27,6% | 114.394 | 27,1% | 1,9% |
| Revenues | 406.232 | 100,0% | 421.931 | 100,0% | 3,9% |
| Gross margin | 176.928 | 43,6% | 188.342 | 44,6% | 6,5% |
| Operating Expenses | 39.445 | 9,7% | 44.550 | 10,6% | 12,9% |
| Staff espenses | 71.561 | 17,6% | 78.155 | 18,5% | 9,2% |
| EBITDA | 65.922 | 16,2% | 65.637 | 15,6% | -0,4% |
| Depr., amort., accruals | 9.025 | 2,2% | 10.602 | 2,5% | 17,5% |
| EBIT | 56.896 | 14,0% | 55.035 | 13,0% | -3,3% |
| Net financ.income(charges) | (693) | -0,2% | (1.778) | -0,4% | 156,5% |
| Other income (expense) net | 5.024 | 1,2% | (1.078) | -0,3% | |
| EBT | 61.228 | 15,1% | 52.180 | 12,4% | -14,8% |
| 31/12/24 | 30/09/25 unaudited |
||||
| Net financial position | 110.559 | 137.399 |

| Euro '000 | 2024-Q3 | % | 2025-Q3 | % | Var. % |
|---|---|---|---|---|---|
| unaudited | unaudited | ||||
| Revenues | 134.761 | 100,0% | 136.595 | 100,0% | 1,4% |
| Gross margin | 57.097 | 42,4% | 62.131 | 45,5% | 8,8% |
| Operating Expenses | 11.327 | 8,4% | 13.607 | 10,0% | 20,1% |
| Staff espenses | 23.227 | 17,2% | 25.110 | 18,4% | 8,1% |
| EBITDA | 22.543 | 16,7% | 23.414 | 17,1% | 3,9% |
| Depr., amort., accruals | 2.910 | 2,2% | 3.027 | 2,2% | 4,0% |
| EBIT | 19.632 | 14,6% | 20.387 | 14,9% | 3,8% |
| Net financ.income(charges) | (723) | -0,5% | 884 | 0,6% | |
| Other income (expense) net | 24 | 0,0% | (817) | -0,6% | |
| EBT | 18.933 | 14,0% | 20.454 | 15,0% | 8,0% |
| _ | - |

certified
<-- PDF CHUNK SEPARATOR -->

* Nopat =Ebit-Income tax

**D&A= Depreciation, Accruals and Devaluation
***NWC= Net Working Capital

Industrial: +2%
in Euro million


Medical: +5%
in Euro million






| Stockholder's Equity per share | 5,2 |
|---|---|
| Price / Book Value Adj. | 2,1 |
| EV /EBIT (95% EBIT) | 10,7 |
| EV / Sales (95% Sales) | 1,4 |
| El.En. Market Cap. | 890,6 @ €11,10 |
|---|---|
| Net financial position | 137,4 @ 30/09/2025 |
| Financial investments m/l term | 10,7 @ 30/09/2025 |
| Enterprise Value | 742,5 |

emanket sdir storage certified
| TM. | |
|---|---|
| ELEN |
| Se t p |
h, 3 0 t |
2 0 2 5 |
|---|---|---|
| -------------- | ------------------- | ------------------ |
| \$ 1 4, 6 1 |
\$ 2 6 7 |
( *) |
( *) |
lu Va e |
|||||
|---|---|---|---|---|---|---|---|---|---|
| -1 0 % |
\$ 5 9 |
2 2 % |
\$ 9 2 3 |
\$ 3 9 6 |
1, 1 |
5, 0 |
1, 4 |
||
| \$ 1, 3 3 |
\$ 2 1 8 |
% -1 3 |
\$ ( ) 2 1 |
% -1 0 |
\$ 1 7 0 |
\$ 3 2 9 |
1, 1 |
n. a. |
2, 6 |
| \$ 8 1, 7 |
\$ 3 4 |
2 % -1 |
\$ ( ) 2 8 |
-6 % 5 |
\$ 3 |
\$ 5 |
0, 1 |
n. a. |
3 1, |
| \$ 0, 9 5 |
\$ 1 6 5 |
-2 % |
\$ 1 3 |
8 % |
\$ 2 8 7 |
\$ 2 6 2 |
0, 8 |
9, 9 |
0, 6 |
| \$ 7 6 3, 5 5 |
\$ 5 9 |
4 2 % |
\$ 3 |
5 % |
\$ 2 7 1 |
\$ 2 4 5 |
3, 1 |
6 8, 0 |
9, 7 |
| \$ 4, 6 6 |
\$ 7 0 |
3 1 % |
\$ 2 5 |
3 6 % |
\$ 4 1 9 |
\$ 3 6 9 |
4, 0 |
1 1, 1 |
4, 4 |
| € 3 3, 6 1 |
€ 1 5 4 |
3 5 % |
€ 7 6 |
4 9 % |
€ 2. 1 9 9 |
€ 2. 1 4 6 |
1 0, 5 |
2 1, 3 |
7, 0 |
| du In |
ia l tr s |
|---|---|
| \$ 8 5, 1 6 |
\$ 7 2 9 |
-2 % |
\$ 1 0 |
1 % |
\$ 3. 5 9 0 |
\$ 2. 7 5 2 |
2, 8 |
2 1 1, 5 |
1, 7 |
|---|---|---|---|---|---|---|---|---|---|
| ¥ 3 9, 4 4 |
¥ 1 2. 7 1 3 |
2 7 % |
¥ 5 5 7 |
4 % |
¥ 4 0. 2 0 0 |
¥ 4 2. 1 5 3 |
2, 5 |
5 6, 9 |
2, 4 |
| C H F 2 4 4 |
C H F 3 0 5 |
-8 % |
-C H F 8 |
-3 % |
C H F 4 5 1 |
C H F 6 8 |
0, 1 |
n. a. |
0, 7 |
| 1. 8 2 6 J P Y |
3 0 6. 1 1 9 J P Y |
% 1 |
3 4. 5 9 7 J P Y |
% 1 1 |
5 9 9. 2 4 0 J P Y |
5 3 0. 4 8 6 J P Y |
1, 3 |
1 1, 5 |
1, 1 |
| 3 2 1 J P Y |
2. 0 0 7 J P Y |
0 % -1 |
-9 0 J P Y |
% -4 |
3 0 1. 4 J P Y |
2. 8 5 1 J P Y |
0, 9 |
n. a. |
2 1, |
| 3, 3 ¥ 7 4 |
0 3 8 ¥ 1 1. |
2 3 % |
0 6 ¥ 1. 5 |
0 % 1 |
2. 8 0 ¥ 7 4 |
0 8 6 ¥ 7 5. |
5, 1 |
3, 0 5 |
6, 6 |
| € 1 1, 1 0 |
€ 4 2 2 |
4 % |
€ 5 5 |
1 3 % |
€ 8 9 1 |
€ 7 4 3 |
1, 4 |
1 0, 7 |
2, 1 |
(1) EV and multiplies as for previous slide

(2) Financials @ 30.06.25
(*) Revenue,Ebit and earnings annualized






El.En. S.P.A.
Enrico RomagnoliInvestor Relations Managertel. +39 055-8826807
E-mail: [email protected]
Financial Communication, IR and Press OfficeBianca Fersini Mastelloni - [email protected] Silvia Marongiu - [email protected] Tel. +39 06-69923324

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.